Therapeutic effectiveness of intratumorally-delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32
Interleukin-32 (IL-32) is a pro-inflammatory cytokine conditionally produced by T cells, natural killer (NK) cells, monocytes, epithelial cells and keratinocytes, that plays an important role in host resistance against infectious disease. Interestingly, elevated levels of IL-32 transcripts in fine n...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348582/ |